Return On Equity of Trevi Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Trevi Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Trevi Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -31%, a 51% increase year-over-year.
  • Trevi Therapeutics, Inc. annual Return On Equity for 2024 was -64%, a 105% decline from 2023.
  • Trevi Therapeutics, Inc. annual Return On Equity for 2023 was -32%, a 22% increase from 2022.
  • Trevi Therapeutics, Inc. annual Return On Equity for 2022 was -40%, a 79% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Trevi Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -31% +32% +51% 01 Jul 2025 30 Sep 2025
Q2 2025 -41% +8.5% +17% 01 Apr 2025 30 Jun 2025
Q1 2025 -58% -19% -48% 01 Jan 2025 31 Mar 2025
Q4 2024 -64% -33% -105% 01 Oct 2024 31 Dec 2024
Q3 2024 -63% -36% -133% 01 Jul 2024 30 Sep 2024
Q2 2024 -50% -24% -89% 01 Apr 2024 30 Jun 2024
Q1 2024 -40% -9.8% -33% 01 Jan 2024 31 Mar 2024
Q4 2023 -32% +8.9% +22% 01 Oct 2023 31 Dec 2023
Q3 2023 -27% +38% +58% 01 Jul 2023 30 Sep 2023
Q2 2023 -26% +99% +79% 01 Apr 2023 30 Jun 2023
Q1 2023 -30% +203% +87% 01 Jan 2023 31 Mar 2023
Q4 2022 -40% +154% +79% 01 Oct 2022 31 Dec 2022
Q3 2022 -65% +110% +63% 01 Jul 2022 30 Sep 2022
Q2 2022 -125% +9.1% +6.8% 01 Apr 2022 30 Jun 2022
Q1 2022 -232% -129% -125% 01 Jan 2022 31 Mar 2022
Q4 2021 -194% -107% -122% 01 Oct 2021 31 Dec 2021
Q3 2021 -175% -107% -159% 01 Jul 2021 30 Sep 2021
Q2 2021 -134% -76% -128% 01 Apr 2021 30 Jun 2021
Q1 2021 -103% -51% -99% 01 Jan 2021 31 Mar 2021
Q4 2020 -88% +67% +43% 01 Oct 2020 31 Dec 2020
Q3 2020 -67% -173% -164% 01 Jul 2020 30 Sep 2020
Q2 2020 -59% -96% -261% 01 Apr 2020 30 Jun 2020
Q1 2020 -52% -72% -357% 01 Jan 2020 31 Mar 2020
Q4 2019 -154% -175% -845% 01 Oct 2019 31 Dec 2019
Q3 2019 106% 01 Jul 2019 30 Sep 2019
Q2 2019 37% 01 Apr 2019 30 Jun 2019
Q1 2019 20% 01 Jan 2019 31 Mar 2019
Q4 2018 21% 01 Oct 2018 31 Dec 2018

Trevi Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -64% -33% -105% 01 Jan 2024 31 Dec 2024
2023 -32% +8.9% +22% 01 Jan 2023 31 Dec 2023
2022 -40% +154% +79% 01 Jan 2022 31 Dec 2022
2021 -194% -107% -122% 01 Jan 2021 31 Dec 2021
2020 -88% +67% +43% 01 Jan 2020 31 Dec 2020
2019 -154% -175% -845% 01 Jan 2019 31 Dec 2019
2018 21% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.